VYNE Therapeutics Inc. (VYNE): Price and Financial Metrics
VYNE Price/Volume Stats
| Current price | $2.82 | 52-week high | $4.24 |
| Prev. close | $2.73 | 52-week low | $1.57 |
| Day low | $2.71 | Volume | 57,700 |
| Day high | $2.89 | Avg. volume | 82,484 |
| 50-day MA | $2.33 | Dividend yield | N/A |
| 200-day MA | $2.26 | Market Cap | 41.60M |
VYNE Stock Price Chart Interactive Chart >
VYNE Therapeutics Inc. (VYNE) Company Bio
VYNE Therapeutics Inc. operates as a clinical stage bio-pharmaceutical company. The Company develops medicines and therapies for the treatment of chronic pruritus and cough. VYNE Therapeutics serves customers worldwide.
VYNE Price Returns
| 1-mo | 17.50% |
| 3-mo | 50.80% |
| 6-mo | 9.30% |
| 1-year | -27.69% |
| 3-year | -85.08% |
| 5-year | -99.01% |
| YTD | 21.03% |
| 2023 | -13.70% |
| 2022 | -85.29% |
| 2021 | -83.86% |
| 2020 | -65.95% |
| 2019 | N/A |
Loading social stream, please wait...